Zika Virus Therapeutic Market, Global Outlook and Forecast 2022-2028

June 2022 | 69 pages | ID: ZD88DA28CBCAEN
Market Monitor Global

Abstracts

Zika virus infection is triggered by an Aedes mosquito-borne virus that bites during the day. In general, the symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise, or headache.

This report contains market size and forecasts of Zika Virus Therapeutic in Global, including the following market information:

Global Zika Virus Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Zika Virus Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Acetaminophen Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Zika Virus Therapeutic include Johnson and Johnson, Aurobindo Pharma, Granules India, Perrigo, Sun Pharmaceutical, Bharat Biotech, Emergent BioSolutions, Takeda Pharmaceutical and GeoVax Labs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zika Virus Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Zika Virus Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Zika Virus Therapeutic Market Segment Percentages, by Type, 2021 (%)

• Acetaminophen
• Other NSAIDs

Global Zika Virus Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Zika Virus Therapeutic Market Segment Percentages, by Application, 2021 (%)

• Institutional Pharmacies
• Retail Pharmacies
• Others

Global Zika Virus Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Zika Virus Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Zika Virus Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Zika Virus Therapeutic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson and Johnson
• Aurobindo Pharma
• Granules India
• Perrigo
• Sun Pharmaceutical
• Bharat Biotech
• Emergent BioSolutions
• Takeda Pharmaceutical
• GeoVax Labs
• IMV
• Inovio Pharmaceuticals
• Moderna
• Merck
• Valneva

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Zika Virus Therapeutic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Zika Virus Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ZIKA VIRUS THERAPEUTIC OVERALL MARKET SIZE

2.1 Global Zika Virus Therapeutic Market Size: 2021 VS 2028
2.2 Global Zika Virus Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Zika Virus Therapeutic Players in Global Market
3.2 Top Global Zika Virus Therapeutic Companies Ranked by Revenue
3.3 Global Zika Virus Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Zika Virus Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Zika Virus Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Zika Virus Therapeutic Players in Global Market
  3.6.1 List of Global Tier 1 Zika Virus Therapeutic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Zika Virus Therapeutic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Zika Virus Therapeutic Market Size Markets, 2021 & 2028
  4.1.2 Acetaminophen
  4.1.3 Other NSAIDs
4.2 By Type - Global Zika Virus Therapeutic Revenue & Forecasts
  4.2.1 By Type - Global Zika Virus Therapeutic Revenue, 2017-2022
  4.2.2 By Type - Global Zika Virus Therapeutic Revenue, 2023-2028
  4.2.3 By Type - Global Zika Virus Therapeutic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Zika Virus Therapeutic Market Size, 2021 & 2028
  5.1.2 Institutional Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Others
5.2 By Application - Global Zika Virus Therapeutic Revenue & Forecasts
  5.2.1 By Application - Global Zika Virus Therapeutic Revenue, 2017-2022
  5.2.2 By Application - Global Zika Virus Therapeutic Revenue, 2023-2028
  5.2.3 By Application - Global Zika Virus Therapeutic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Zika Virus Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Zika Virus Therapeutic Revenue & Forecasts
  6.2.1 By Region - Global Zika Virus Therapeutic Revenue, 2017-2022
  6.2.2 By Region - Global Zika Virus Therapeutic Revenue, 2023-2028
  6.2.3 By Region - Global Zika Virus Therapeutic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Zika Virus Therapeutic Revenue, 2017-2028
  6.3.2 US Zika Virus Therapeutic Market Size, 2017-2028
  6.3.3 Canada Zika Virus Therapeutic Market Size, 2017-2028
  6.3.4 Mexico Zika Virus Therapeutic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Zika Virus Therapeutic Revenue, 2017-2028
  6.4.2 Germany Zika Virus Therapeutic Market Size, 2017-2028
  6.4.3 France Zika Virus Therapeutic Market Size, 2017-2028
  6.4.4 U.K. Zika Virus Therapeutic Market Size, 2017-2028
  6.4.5 Italy Zika Virus Therapeutic Market Size, 2017-2028
  6.4.6 Russia Zika Virus Therapeutic Market Size, 2017-2028
  6.4.7 Nordic Countries Zika Virus Therapeutic Market Size, 2017-2028
  6.4.8 Benelux Zika Virus Therapeutic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Zika Virus Therapeutic Revenue, 2017-2028
  6.5.2 China Zika Virus Therapeutic Market Size, 2017-2028
  6.5.3 Japan Zika Virus Therapeutic Market Size, 2017-2028
  6.5.4 South Korea Zika Virus Therapeutic Market Size, 2017-2028
  6.5.5 Southeast Asia Zika Virus Therapeutic Market Size, 2017-2028
  6.5.6 India Zika Virus Therapeutic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Zika Virus Therapeutic Revenue, 2017-2028
  6.6.2 Brazil Zika Virus Therapeutic Market Size, 2017-2028
  6.6.3 Argentina Zika Virus Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Zika Virus Therapeutic Revenue, 2017-2028
  6.7.2 Turkey Zika Virus Therapeutic Market Size, 2017-2028
  6.7.3 Israel Zika Virus Therapeutic Market Size, 2017-2028
  6.7.4 Saudi Arabia Zika Virus Therapeutic Market Size, 2017-2028
  6.7.5 UAE Zika Virus Therapeutic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson and Johnson
  7.1.1 Johnson and Johnson Corporate Summary
  7.1.2 Johnson and Johnson Business Overview
  7.1.3 Johnson and Johnson Zika Virus Therapeutic Major Product Offerings
  7.1.4 Johnson and Johnson Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.1.5 Johnson and Johnson Key News
7.2 Aurobindo Pharma
  7.2.1 Aurobindo Pharma Corporate Summary
  7.2.2 Aurobindo Pharma Business Overview
  7.2.3 Aurobindo Pharma Zika Virus Therapeutic Major Product Offerings
  7.2.4 Aurobindo Pharma Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.2.5 Aurobindo Pharma Key News
7.3 Granules India
  7.3.1 Granules India Corporate Summary
  7.3.2 Granules India Business Overview
  7.3.3 Granules India Zika Virus Therapeutic Major Product Offerings
  7.3.4 Granules India Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.3.5 Granules India Key News
7.4 Perrigo
  7.4.1 Perrigo Corporate Summary
  7.4.2 Perrigo Business Overview
  7.4.3 Perrigo Zika Virus Therapeutic Major Product Offerings
  7.4.4 Perrigo Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.4.5 Perrigo Key News
7.5 Sun Pharmaceutical
  7.5.1 Sun Pharmaceutical Corporate Summary
  7.5.2 Sun Pharmaceutical Business Overview
  7.5.3 Sun Pharmaceutical Zika Virus Therapeutic Major Product Offerings
  7.5.4 Sun Pharmaceutical Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.5.5 Sun Pharmaceutical Key News
7.6 Bharat Biotech
  7.6.1 Bharat Biotech Corporate Summary
  7.6.2 Bharat Biotech Business Overview
  7.6.3 Bharat Biotech Zika Virus Therapeutic Major Product Offerings
  7.6.4 Bharat Biotech Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.6.5 Bharat Biotech Key News
7.7 Emergent BioSolutions
  7.7.1 Emergent BioSolutions Corporate Summary
  7.7.2 Emergent BioSolutions Business Overview
  7.7.3 Emergent BioSolutions Zika Virus Therapeutic Major Product Offerings
  7.7.4 Emergent BioSolutions Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.7.5 Emergent BioSolutions Key News
7.8 Takeda Pharmaceutical
  7.8.1 Takeda Pharmaceutical Corporate Summary
  7.8.2 Takeda Pharmaceutical Business Overview
  7.8.3 Takeda Pharmaceutical Zika Virus Therapeutic Major Product Offerings
  7.8.4 Takeda Pharmaceutical Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.8.5 Takeda Pharmaceutical Key News
7.9 GeoVax Labs
  7.9.1 GeoVax Labs Corporate Summary
  7.9.2 GeoVax Labs Business Overview
  7.9.3 GeoVax Labs Zika Virus Therapeutic Major Product Offerings
  7.9.4 GeoVax Labs Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.9.5 GeoVax Labs Key News
7.10 IMV
  7.10.1 IMV Corporate Summary
  7.10.2 IMV Business Overview
  7.10.3 IMV Zika Virus Therapeutic Major Product Offerings
  7.10.4 IMV Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.10.5 IMV Key News
7.11 Inovio Pharmaceuticals
  7.11.1 Inovio Pharmaceuticals Corporate Summary
  7.11.2 Inovio Pharmaceuticals Business Overview
  7.11.3 Inovio Pharmaceuticals Zika Virus Therapeutic Major Product Offerings
  7.11.4 Inovio Pharmaceuticals Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.11.5 Inovio Pharmaceuticals Key News
7.12 Moderna
  7.12.1 Moderna Corporate Summary
  7.12.2 Moderna Business Overview
  7.12.3 Moderna Zika Virus Therapeutic Major Product Offerings
  7.12.4 Moderna Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.12.5 Moderna Key News
7.13 Merck
  7.13.1 Merck Corporate Summary
  7.13.2 Merck Business Overview
  7.13.3 Merck Zika Virus Therapeutic Major Product Offerings
  7.13.4 Merck Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.13.5 Merck Key News
7.14 Valneva
  7.14.1 Valneva Corporate Summary
  7.14.2 Valneva Business Overview
  7.14.3 Valneva Zika Virus Therapeutic Major Product Offerings
  7.14.4 Valneva Zika Virus Therapeutic Revenue in Global Market (2017-2022)
  7.14.5 Valneva Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Zika Virus Therapeutic Market Opportunities & Trends in Global Market
Table 2. Zika Virus Therapeutic Market Drivers in Global Market
Table 3. Zika Virus Therapeutic Market Restraints in Global Market
Table 4. Key Players of Zika Virus Therapeutic in Global Market
Table 5. Top Zika Virus Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Zika Virus Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Zika Virus Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Zika Virus Therapeutic Product Type
Table 9. List of Global Tier 1 Zika Virus Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Zika Virus Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Zika Virus Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Zika Virus Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Zika Virus Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Zika Virus Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Zika Virus Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Zika Virus Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Zika Virus Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Zika Virus Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Zika Virus Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Zika Virus Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Zika Virus Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Zika Virus Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Zika Virus Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Zika Virus Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. Johnson and Johnson Corporate Summary
Table 31. Johnson and Johnson Zika Virus Therapeutic Product Offerings
Table 32. Johnson and Johnson Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. Aurobindo Pharma Corporate Summary
Table 34. Aurobindo Pharma Zika Virus Therapeutic Product Offerings
Table 35. Aurobindo Pharma Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. Granules India Corporate Summary
Table 37. Granules India Zika Virus Therapeutic Product Offerings
Table 38. Granules India Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. Perrigo Corporate Summary
Table 40. Perrigo Zika Virus Therapeutic Product Offerings
Table 41. Perrigo Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. Sun Pharmaceutical Corporate Summary
Table 43. Sun Pharmaceutical Zika Virus Therapeutic Product Offerings
Table 44. Sun Pharmaceutical Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. Bharat Biotech Corporate Summary
Table 46. Bharat Biotech Zika Virus Therapeutic Product Offerings
Table 47. Bharat Biotech Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 48. Emergent BioSolutions Corporate Summary
Table 49. Emergent BioSolutions Zika Virus Therapeutic Product Offerings
Table 50. Emergent BioSolutions Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 51. Takeda Pharmaceutical Corporate Summary
Table 52. Takeda Pharmaceutical Zika Virus Therapeutic Product Offerings
Table 53. Takeda Pharmaceutical Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 54. GeoVax Labs Corporate Summary
Table 55. GeoVax Labs Zika Virus Therapeutic Product Offerings
Table 56. GeoVax Labs Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 57. IMV Corporate Summary
Table 58. IMV Zika Virus Therapeutic Product Offerings
Table 59. IMV Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 60. Inovio Pharmaceuticals Corporate Summary
Table 61. Inovio Pharmaceuticals Zika Virus Therapeutic Product Offerings
Table 62. Inovio Pharmaceuticals Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 63. Moderna Corporate Summary
Table 64. Moderna Zika Virus Therapeutic Product Offerings
Table 65. Moderna Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 66. Merck Corporate Summary
Table 67. Merck Zika Virus Therapeutic Product Offerings
Table 68. Merck Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)
Table 69. Valneva Corporate Summary
Table 70. Valneva Zika Virus Therapeutic Product Offerings
Table 71. Valneva Zika Virus Therapeutic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Zika Virus Therapeutic Segment by Type in 2021
Figure 2. Zika Virus Therapeutic Segment by Application in 2021
Figure 3. Global Zika Virus Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Zika Virus Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Zika Virus Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Zika Virus Therapeutic Revenue in 2021
Figure 8. By Type - Global Zika Virus Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Zika Virus Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Zika Virus Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Zika Virus Therapeutic Revenue Market Share, 2017-2028
Figure 12. US Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Zika Virus Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Zika Virus Therapeutic Revenue Market Share, 2017-2028
Figure 24. China Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Zika Virus Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Zika Virus Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Zika Virus Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson and Johnson Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Aurobindo Pharma Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Granules India Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Perrigo Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sun Pharmaceutical Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bharat Biotech Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Emergent BioSolutions Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Takeda Pharmaceutical Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GeoVax Labs Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. IMV Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Inovio Pharmaceuticals Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Moderna Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Merck Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Valneva Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)